Ann: First Australian Patient Dosed in Phase 1b azer-cel Trial, page-222

  1. 1,631 Posts.
    lightbulb Created with Sketch. 13856

    Clearly demonstrating you have no idea what you are investing in.

    Blinatumomab targets CD19, which OnCARlytics is being used in combination with.

    Honestly.

    https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2023-08528
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.4¢
Change
-0.001(6.67%)
Mkt cap ! $104.5M
Open High Low Value Volume
1.5¢ 1.5¢ 1.3¢ $255.7K 18.24M

Buyers (Bids)

No. Vol. Price($)
65 18692454 1.3¢
 

Sellers (Offers)

Price($) Vol. No.
1.4¢ 4515891 5
View Market Depth
Last trade - 16.10pm 17/06/2025 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.